← Eichor
Study identifier: NCT03059043 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Safety and Efficacy Study of A Viscoelastic-free Method for Implantable Collamer Lens (ICL) Implantation

Condition: Myopia  ·  Sponsor: Wenzhou Medical University

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 45 Years
Healthy volunteersYes

About this study

This study evaluates the safety and efficacy of a viscoelastic-free method for Implantable Collamer Lens(ICL) implantation to treat high myopia. The subjects undergo randomization of ICL implantation using the viscoelastic-free method on one eye and undergoing standard method on the other one. The post-operative data are collected for analysis.

This description comes directly from the study's public registry record.

Talk to the study team

AYong Yu, MD. PhD.  ·  +86-0577-88068880  ·  yaybetter@hotmail.com

Anpeng Pan, MD.OD.  ·  pananpeng@126.com

Always discuss trial participation with your own doctor first.

Locations (5)

Guangdong General HospitalGuangzhou, Guangdong, ChinaNot Yet Recruiting
Hunan Provincial People's HospitalChangsha, Hunan, ChinaNot Yet Recruiting
The Eye Hispital of Wenzhou Medical UniversityWenzhou, Zhejiang, ChinaRecruiting
Peking Union Medical College HospitalBeijing, ChinaNot Yet Recruiting
Shanghai Ninth People's HospitalShanghai, ChinaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03059043